Medical Net, Inc. - Laporan Laba Rugi (TTM)

Medical Net, Inc.
JP ˙ TSE
JP¥ 321.00 ↓ -3.00 (-0.93%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Medical Net, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
11-30
2021
02-28
2021
05-31
2021
08-31
2021
11-30
2022
02-28
2022
05-31
2022
08-31
2022
11-30
2023
02-28
2023
05-31
2023
08-31
2023
11-30
2024
02-29
2024
05-31
2024
08-31
2024
11-30
2025
02-28
2025
05-31
Revenue 3,067 3,212 3,330 3,425 3,440 3,453 3,745 3,913 4,040 4,279 4,500 4,628 4,845 5,030 5,252 5,511 5,822 6,018 6,077
Change (%) 4.73 3.67 2.85 0.44 0.38 8.46 4.49 3.25 5.92 5.16 2.84 4.69 3.82 4.41 4.93 5.64 3.37 0.98
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 2,013 2,103 2,153 2,172 2,134 2,108 2,285 2,374 2,446 2,609 2,720 2,862 3,002 3,182 3,411 3,595 3,876 4,030 4,112
Change (%) 4.47 2.38 0.88 -1.75 -1.22 8.40 3.89 3.03 6.66 4.25 5.22 4.89 6.00 7.20 5.39 7.82 3.97 2.03
% of Revenue 65.63 65.47 64.65 63.42 62.03 61.05 61.01 60.67 60.54 60.97 60.44 61.84 61.96 63.26 64.95 65.23 66.58 66.97 67.66
Gross Operating Profit 1,054 1,109 1,177 1,253 1,306 1,345 1,460 1,539 1,594 1,670 1,780 1,766 1,843 1,848 1,841 1,916 1,946 1,988 1,965
Change (%) 5.22 6.13 6.46 4.23 2.99 8.55 5.41 3.57 4.77 6.59 -0.79 4.36 0.27 -0.38 4.07 1.57 2.16 -1.16
% of Revenue 34.37 34.53 35.35 36.58 37.97 38.95 38.99 39.33 39.46 39.03 39.56 38.16 38.04 36.74 35.05 34.77 33.42 33.03 32.34
SG&A 834 831 846 870 905 920 1,010 1,097 1,202 1,336 1,401 1,456 1,487 1,497 1,542 1,644 1,768 1,861 1,866
Change (%) -0.36 1.81 2.84 4.02 1.66 9.78 8.61 9.57 11.15 4.87 3.93 2.13 0.67 3.01 6.61 7.54 5.26 0.27
% of Revenue 27.19 25.87 25.41 25.40 26.31 26.64 26.97 28.03 29.75 31.22 31.13 31.46 30.69 29.76 29.36 29.83 30.37 30.92 30.71
R&D
Change (%)
% of Revenue
OpEx 2,847 2,934 2,999 3,042 3,039 3,028 3,295 3,471 3,648 3,945 4,121 4,318 4,489 4,679 4,953 5,239 5,644 5,891 5,978
Change (%) 3.06 2.22 1.43 -0.10 -0.36 8.82 5.34 5.10 8.14 4.46 4.78 3.96 4.23 5.86 5.77 7.73 4.38 1.48
% of Revenue 92.83 91.34 90.06 88.82 88.34 87.69 87.98 88.70 90.30 92.19 91.58 93.30 92.65 93.02 94.31 95.06 96.94 97.89 98.37
Operating Income 220 278 331 383 401 425 450 442 392 334 379 310 356 351 299 272 178 127 99
Change (%) 26.36 19.06 15.71 4.70 5.99 5.88 -1.78 -11.31 -14.80 13.47 -18.21 14.84 -1.40 -14.81 -9.03 -34.56 -28.65 -22.05
% of Revenue 7.17 8.66 9.94 11.18 11.66 12.31 12.02 11.30 9.70 7.81 8.42 6.70 7.35 6.98 5.69 4.94 3.06 2.11 1.63
Interest Expense -3 -2 -1 -1 0 -1 -1 -2 -2 -3 -3 -3 -4 -3 -6 -7 -9 -11 -11
Change (%) -33.33 -50.00 -0.00 -100.00 -∞ -0.00 100.00 -0.00 50.00 -0.00 -0.00 33.33 -25.00 100.00 16.67 28.57 22.22 -0.00
% of Revenue -0.10 -0.06 -0.03 -0.03 0.00 -0.03 -0.03 -0.05 -0.05 -0.07 -0.07 -0.06 -0.08 -0.06 -0.11 -0.13 -0.15 -0.18 -0.18
Net Income 101 116 129 247 310 328 384 294 268 191 116 80 101 23 5 -51 -127 -186 -68
Change (%) 14.85 11.21 91.47 25.51 5.81 17.07 -23.44 -8.84 -28.73 -39.27 -31.03 26.25 -77.23 -78.26 -1,120.00 149.02 46.46 -63.44
% of Revenue 3.29 3.61 3.87 7.21 9.01 9.50 10.25 7.51 6.63 4.46 2.58 1.73 2.08 0.46 0.10 -0.93 -2.18 -3.09 -1.12

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista